CBLL
CeriBell (CBLL)
$42
About CeriBell (CBLL)
Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.
Details
Daily high
$21.65
Daily low
$21.01
Price at open
$21.25
52 Week High
$27.22
52 Week Low
$10.01
Market cap
794.6M
Dividend yield
0.00%
Volume
206,055
Avg. volume
571,751
P/E ratio
-14.79
CeriBell News
Details
Daily high
$21.65
Daily low
$21.01
Price at open
$21.25
52 Week High
$27.22
52 Week Low
$10.01
Market cap
794.6M
Dividend yield
0.00%
Volume
206,055
Avg. volume
571,751
P/E ratio
-14.79